This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Universitë De Bordeaux, Université´ D'aix-Marseille. Active years: 2019.
Company Filing History:
1 out of 5,383 
1 out of 226 
1 out of 236 
Years Active: 2019
Title: Philippe Mellet: Innovator in Cancer Treatment
Introduction
Philippe Mellet is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on developing new compounds that can potentially improve therapeutic outcomes for cancer patients.
Latest Patents
Philippe Mellet holds a patent for "Alkoxyamines for the treatment of cancers." This invention relates to alkoxyamines of general formula (I), and to compounds of general formula (IIa), (IIb), (IIc), (IId), (IIe), (IIf), or (IIg), which are designed for the treatment of cancers. This patent represents a significant advancement in the search for effective cancer therapies.
Career Highlights
Throughout his career, Philippe Mellet has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and Université d'Aix-Marseille. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Philippe has collaborated with notable colleagues, including Sylvain Marque and Jean-Michel Franconi. These partnerships have enriched his research and have been instrumental in the development of his innovative ideas.
Conclusion
Philippe Mellet's work in the field of cancer treatment exemplifies the impact of innovation in medicine. His patent for alkoxyamines highlights his commitment to advancing therapeutic options for patients. Through his collaborations and career achievements, he continues to contribute to the scientific community and the fight against cancer.